EU veterinary big data workplan to 2025
Submitted by Anonymous (not verified) on 28 August 2023 - 14:55
EU veterinary big data workplan to 2025
Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Gaucher Disease, Date of authorisation: 19/01/2015, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 28 August 2023 - 14:44
Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Gaucher Disease, Date of authorisation: 19/01/2015, Revision: 16, Status: Authorised
Opinion/decision on a Paediatric investigation plan (PIP): lademirsen, decision type: , therapeutic area: , PIP number: P/0336/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 12:15
Opinion/decision on a Paediatric investigation plan (PIP): lademirsen, decision type: , therapeutic area: , PIP number: P/0336/2022
Opinion/decision on a Paediatric investigation plan (PIP): Etrasimod L-arginine, decision type: , therapeutic area: , PIP number: P/0346/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 11:45
Opinion/decision on a Paediatric investigation plan (PIP): Etrasimod L-arginine, decision type: , therapeutic area: , PIP number: P/0346/2022
Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli,Pegcetacoplan, decision type: , therapeutic area: , PIP number: P/0284/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 10:06
Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli,Pegcetacoplan, decision type: , therapeutic area: , PIP number: P/0284/2022
Opinion/decision on a Paediatric investigation plan (PIP): Gliadin protease, decision type: , therapeutic area: , PIP number: P/0268/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 9:45
Opinion/decision on a Paediatric investigation plan (PIP): Gliadin protease, decision type: , therapeutic area: , PIP number: P/0268/2022
Opinion/decision on a Paediatric investigation plan (PIP): Remibrutinib, decision type: , therapeutic area: , PIP number: P/0345/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 9:37
Opinion/decision on a Paediatric investigation plan (PIP): Remibrutinib, decision type: , therapeutic area: , PIP number: P/0345/2022
Opinion/decision on a Paediatric investigation plan (PIP): Nipocalimab, decision type: , therapeutic area: , PIP number: P/0344/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 9:28
Opinion/decision on a Paediatric investigation plan (PIP): Nipocalimab, decision type: , therapeutic area: , PIP number: P/0344/2022
Opinion/decision on a Paediatric investigation plan (PIP): Efruxifermin, decision type: , therapeutic area: , PIP number: P/0302/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 9:11
Opinion/decision on a Paediatric investigation plan (PIP): Efruxifermin, decision type: , therapeutic area: , PIP number: P/0302/2022
Opinion/decision on a Paediatric investigation plan (PIP): 2’-O-(2’-methoxyethyl) modified antisense oligonucleotide targeting prekallikrein mRNA (ISIS 721744), decision type: , therapeutic area: , PIP number: P/0274/2022
Submitted by Anonymous (not verified) on 28 August 2023 - 8:31
Opinion/decision on a Paediatric investigation plan (PIP): 2’-O-(2’-methoxyethyl) modified antisense oligonucleotide targeting prekallikrein mRNA (ISIS 721744), decision type: , therapeutic area: , PIP number: P/0274/2022